PubMed Health⌕ Search

Biomedical subjects

M Schick

Publications and source records attributed to M Schick.

69 records · Page 4Linked to original sources

Humoral immune response to herpes simplex virus type 2 glycoproteins in patients receiving a glycoprotein subunit vaccine.

Serial serum specimens from 22 herpes simplex virus (HSV)-seronegative recipients of an HSV type 2 (HSV-2) glycoprotein subunit vaccine were analyzed by radioimmunoprecipitation and polyacrylamide gel electrophoresis for the development of antibodies to HSV-2 gB, gD, and g80, a complex of gC and gE. Volunteers received 50 (n = 12) or 100 micrograms (n = 10) of vaccine at days 0, 28, and 140; sera were drawn weekly for 8 weeks and again at days 140, 147, and 365. Among seronegative volunteers, antibody to gB was detected 2 weeks after the first dose, while antibodies to g80 and gD were detected after the second dose (day 35). Antibodies to nonglycosylated HSV-specific proteins were not detected. A dose-response effect between recipients of 50- and 100-micrograms doses was observed in the proportion of vaccine recipients seroconverting to g80 and in the proportion of recipients retaining antibodies to both gD and g80 over time. Diminishing complement-independent neutralizing antibody titers occurred after the second dose and were associated with loss or reduction of detectable antibody to gD. Volunteers who were seropositive for HSV-1-specific antibody (n = 11) were also enrolled in the trial and received 50-micrograms doses of vaccine. Vaccination resulted in conversion to HSV-2 complement-independent neutralizing antibody specificity or indeterminant specificity in 10 of 11 volunteers. These shifts were accompanied by changes in the radioimmunoprecipitation and polyacrylamide gel electrophoresis profile. These changes, which were apparent by 14 days after the first vaccine dose, included de novo appearance or increased levels of antibody to g80 and increased levels of antibody to gD and gB. These studies document the immunogenicity of solubilized glycoproteins gB, gD, gC, and, possibly, gE in humans.

Antibodies, Viral↗

Alcohol intake, tumour necrosis factor-alpha, leptin and craving: factors of a possibly vicious circle?

AIMS: Since the appetite-regulating peptide leptin was recently found to be highly correlated with both craving for alcohol and lifetime ethanol intake, the aim of our study was to test the hypothesis whether tumour necrosis factor-alpha (TNF-alpha) might be the factor that links alcohol intake with elevated leptin levels. METHODS: TNF-alpha, leptin, and alcohol craving were assessed in male alcohol addicts at the onset of alcohol withdrawal and in matched controls. RESULTS: Increased leptin plasma levels in alcohol addicts correlated significantly with an enhanced secretion of TNF-alpha, which was itself related to the duration of alcohol misuse. CONCLUSIONS: Since leptin was shown to be associated with alcohol craving, a possible vicious circle is suggested, including the components: alcohol intake, increase of TNF-alpha, enhanced leptin secretion, enhanced alcohol craving, and consecutively increased alcohol intake.

Adult↗